MAHWAH, N.J., Dec. 7, 2017 /PRNewswire/ -- Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the first patient has been dosed in a Phase 1 trial of GBR 1342 ...

Since 2017, he has been able to point to 112 reefs in the Great Barrier Reef (GBR) – comprising roughly 3% of its total size – that his team’s modelling shows are particularly resilient ...

Chris McGrath does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...